Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

More articles from Cancer Therapeutics Insights

  • Hsp90 Inhibitors Promote p53-Dependent Apoptosis through PUMA and Bax
    Kan He, Xingnan Zheng, Lin Zhang, Jian Yu
    Molecular Cancer Therapeutics Nov 2013, 12 (11) 2559-2568; DOI: 10.1158/1535-7163.MCT-13-0284
  • Contribution of ATM and ATR to the Resistance of Glioblastoma and Malignant Melanoma Cells to the Methylating Anticancer Drug Temozolomide
    Marcus Eich, Wynand Paul Roos, Teodora Nikolova, Bernd Kaina
    Molecular Cancer Therapeutics Nov 2013, 12 (11) 2529-2540; DOI: 10.1158/1535-7163.MCT-13-0136
  • The Cannabinoid WIN 55,212-2 Decreases Specificity Protein Transcription Factors and the Oncogenic Cap Protein eIF4E in Colon Cancer Cells
    Sandeep Sreevalsan, Stephen Safe
    Molecular Cancer Therapeutics Nov 2013, 12 (11) 2483-2493; DOI: 10.1158/1535-7163.MCT-13-0486
  • Arginine Deiminase Resistance in Melanoma Cells Is Associated with Metabolic Reprogramming, Glucose Dependence, and Glutamine Addiction
    Yan Long, Wen-Bin Tsai, Medhi Wangpaichitr, Takashi Tsukamoto, Niramol Savaraj, Lynn G. Feun, Macus Tien Kuo
    Molecular Cancer Therapeutics Nov 2013, 12 (11) 2581-2590; DOI: 10.1158/1535-7163.MCT-13-0302
  • Combining Erlotinib and Cetuximab Is Associated with Activity in Patients with Non–Small Cell Lung Cancer (Including Squamous Cell Carcinomas) and Wild-Type EGFR or Resistant Mutations
    Jennifer J. Wheler, Apostolia M. Tsimberidou, Gerald S. Falchook, Ralph G. Zinner, David S. Hong, Jansina Y. Fok, Siqing Fu, Sarina A. Piha-Paul, Aung Naing, Razelle Kurzrock
    Molecular Cancer Therapeutics Oct 2013, 12 (10) 2167-2175; DOI: 10.1158/1535-7163.MCT-12-1208
  • Cetuximab Reverses the Warburg Effect by Inhibiting HIF-1–Regulated LDH-A
    Haiquan Lu, Xinqun Li, Zhongguang Luo, Jie Liu, Zhen Fan
    Molecular Cancer Therapeutics Oct 2013, 12 (10) 2187-2199; DOI: 10.1158/1535-7163.MCT-12-1245
  • PI3K Stimulates DNA Synthesis and Cell-Cycle Progression via Its p55PIK Regulatory Subunit Interaction with PCNA
    Guihua Wang, Xiaonian Cao, Senyan Lai, Xuelai Luo, Yongdong Feng, Xianmin Xia, Paul M. Yen, Jianping Gong, Junbo Hu
    Molecular Cancer Therapeutics Oct 2013, 12 (10) 2100-2109; DOI: 10.1158/1535-7163.MCT-12-0920
  • Chemotherapy Counteracts Metastatic Dissemination Induced by Antiangiogenic Treatment in Mice
    Alessandra Rovida, Vittoria Castiglioni, Alessandra Decio, Valentina Scarlato, Eugenio Scanziani, Raffaella Giavazzi, Marta Cesca
    Molecular Cancer Therapeutics Oct 2013, 12 (10) 2237-2247; DOI: 10.1158/1535-7163.MCT-13-0244
  • Subtype-Specific MEK-PI3 Kinase Feedback as a Therapeutic Target in Pancreatic Adenocarcinoma
    Olga K. Mirzoeva, Eric A. Collisson, Peter M. Schaefer, Byron Hann, Yun K. Hom, Andrew H. Ko, W. Michael Korn
    Molecular Cancer Therapeutics Oct 2013, 12 (10) 2213-2225; DOI: 10.1158/1535-7163.MCT-13-0104
  • Histone Deacetylase Inhibition Overcomes Drug Resistance through a miRNA-Dependent Mechanism
    Tracy Murray-Stewart, Christin L. Hanigan, Patrick M. Woster, Laurence J. Marton, Robert A. Casero
    Molecular Cancer Therapeutics Oct 2013, 12 (10) 2088-2099; DOI: 10.1158/1535-7163.MCT-13-0418

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 11
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement